Cargando…
Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
Autor principal: | Wolf, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734048/ https://www.ncbi.nlm.nih.gov/pubmed/31516832 http://dx.doi.org/10.1016/j.ymgmr.2019.100511 |
Ejemplares similares
-
Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
por: Favresse, Julien, et al.
Publicado: (2019) -
An Analysis of the Biotin–(Strept)avidin System in Immunoassays: Interference and Mitigation Strategies
por: Balzer, Amy H. A., et al.
Publicado: (2023) -
Detection of Toxoplasma gondii in cat’s internal organs by immunohistochemistry methods labeled with-[strept] avidin-biotin
por: Hanafiah, Muhammad, et al.
Publicado: (2017) -
Development and Evaluation of an Anti-Biotin Interference Method in Biotin-Streptavidin Immunoassays
por: Liu, Dong, et al.
Publicado: (2022) -
Chemistry of Biotin–Streptavidin
and the Growing
Concern of an Emerging Biotin Interference in Clinical Immunoassays
por: Luong, John H. T., et al.
Publicado: (2019)